Tacrolimus and Dipyrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Dipyrone (metamizole). Common drug interactions include respiratory failure among females and urinary fistula among males.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Dipyrone. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Dipyrone?

Dipyrone has active ingredients of metamizole. eHealthMe is studying from 1,876 Dipyrone users. Check the latest studies of Dipyrone.



On Jul, 29, 2026

14 people who take Tacrolimus and Dipyrone together, and have interactions are studied.

Tacrolimus and Dipyrone drug interactions.

What are the common drug interactions of Tacrolimus and Dipyrone, by gender? *:

female:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Respiratory syncytial virus infection (viral disease of respiratory system)
  3. Secretion discharge
  4. Septic shock (shock due to blood infection)
  5. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
  6. Visual acuity reduced (reduced clearness of vision)
  7. Weight increased
  8. Abortion induced (medically referred abortion)
  9. Death
  10. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

male:

  1. Urinary fistula
  2. Cough
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Epistaxis (bleed from the nose)
  5. Headache (pain in head)
  6. Hypotension (abnormally low blood pressure)
  7. Mydriasis (a dilation of the pupil)
  8. Neurological symptom (symptoms of nervous system disease)
  9. Oxygen saturation decreased
  10. Pain

What are the common drug interactions of Tacrolimus and Dipyrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Neurogenic shock (insufficient blood flow throughout the body due to injury in spinal cord)
  2. Pyrexia (fever)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Tinnitus (a ringing in the ears)
  5. Vasculitis (inflammation of a blood vessel or blood vessels)
  6. Visceral congestion (blocking of internal organs of the body)
  7. Visual acuity reduced (reduced clearness of vision)
  8. Visual impairment
  9. Bradycardia (abnormally slow heart action)
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Back pain
  3. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  4. Butterfly rash
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Chest pain
  7. Confusional state
  8. Diarrhoea
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

30-39:

  1. Urinary fistula

40-49:

  1. Hepatic artery stenosis (the abnormal narrowing of a hepatic artery)
  2. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  3. Neutropenia (an abnormally low number of neutrophils)

50-59:

n/a

60+:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Pruritus (severe itching of the skin)
  3. Cough
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Epstein-barr virus infection
  8. Gait disturbance
  9. Gamma-glutamyltransferase increased
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 35.71%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 14.29%
  3. Pain: 2 people, 14.29%
  4. Kidney Transplant Rejection: 2 people, 14.29%
  5. Embolism Venous (embolus may pass into the arterial system): 2 people, 14.29%
  6. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 7.14%
  7. Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 7.14%
  8. Nausea (feeling of having an urge to vomit): 1 person, 7.14%
  9. Kidney Stones: 1 person, 7.14%
  10. High Blood Cholesterol: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Dipyrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tacrolimus and Dipyrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dipyrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dipyrone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and metamizole (the active ingredients of Tacrolimus and Dipyrone, respectively), and Tacrolimus and Dipyrone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: